{"nct_id":"NCT02735915","title":"Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older","status":"COMPLETED","status_verified_date":"2024-04","start_date":"2016-04-11","start_date_type":"ACTUAL","primary_completion_date":"2017-08-28","primary_completion_date_type":"ACTUAL","completion_date":"2018-10-08","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}